News•Apr 9, 2026
How to Build an Effective Environmental Monitoring Program Under Annex 1
The EU GMP Annex 1 revision reclassifies Environmental Monitoring (EM) from a compliance checkbox to a core element of sterile‑product contamination control. Legacy, sampling‑driven EM programs no longer satisfy regulators; they must be rebuilt on risk‑based assessments, integrated with cleaning, HVAC and gowning controls, and driven by data trends. Companies that adopt a structured, data‑focused EM strategy can better prevent excursions, protect batch release, and safeguard patient safety.
By Pharma Mirror Magazine
